Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Journal of Labelled Compounds & Radiopharmaceuticals|February 11, 2017
cGMP production of the radiopharmaceutical [18 F]MK-6240 for PET imaging of human neurofibrillary tanglesThomas Lee Collier, Daniel L Yokell, Eli Livni, et al.
Nature Communications|June 14, 2024
Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathiesAnton Lindberg, Emily Murrell, Junchao Tong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 24, 2016
Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human SubjectsDustin W Wooten, Nicolas J Guehl, Eline E Verwer, et al.
Acta Pharmaceutica Sinica. B|March 1, 2021
Recent developments on PET radiotracers for TSPO and their applications in neuroimagingLingling Zhang, Kuan Hu, Tuo Shao, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's DiseaseSteven H Liang, Adam G Southon, Benjamin H Fraser, et al.
Nature Communications|December 5, 2025
Iron-catalyzed three-component amino(radio)fluorination of alkenes to unprotected β-(radio)fluoroaminesYang Li, Yu Zhou, Mark R Bortolus, et al.
Molecular Pharmaceutics|January 5, 2018
Metal Protein-Attenuating Compound for PET Neuroimaging: Synthesis and Preclinical Evaluation of [11C]PBT2Hema S Krishnan, Vadim Bernard-Gauthier, Michael S Placzek, et al.
Molecular Imaging|September 18, 2023
First-in-Human PET Imaging of [18F]SDM-4MP3: A Cautionary TaleKimberly L Desmond, Anton Lindberg, Armando Garcia, et al.
Neuropharmacology|March 30, 2025
Fatty acid amide hydrolase in comorbid borderline personality disorder and major depressive disorder: Imaging with [11C]CURB PETMichelle A De Pol, Dorsa Rafiei, Jeffrey H Meyer, et al.
Pageof 19